Superhero movies, with their emphasis on mad-science mutation, have a retrofuturist appeal.
Men who inherit this mutation have a significant increase in risk of prostate cancer.
By contrast, young women with breast cancer but no BRCA mutation have a 10percentt lifetime risk of cancer in the second breast, and only a 2percentt risk of ovarian cancer.
Steven McCarroll, a geneticist at Harvard, notes that autistic children with the cancer gene mutation have "a brain that is failing in many ways".
Patients with metastatic melanoma, 50% of whose tumours harbour a BRAF mutation, have a poor prognosis.
While the increase in kcat is temperature-independent, the increase in stability shows that the resultant interactions of this mutation have a strong enthalpic component.
Men who carry a BRCA gene mutation have a 7-10% lifetime risk of breast cancer, which is approaching the general population women's risk of breast cancer.
This demonstrates that HSCR patients with the RETR114H mutation have a common ancestor.
Women with a mutation have a 65% risk of developing breast cancer before age 70 [9].
Our results show that melanoma cells harboring the BRAFV600E oncogenic mutation have a very limited response to metabolic stress.
We tested whether APLP2 KO mice carrying the APPTA mutation have a lethal phenotype, similar to the APP/APLP2 dKO mice.
